These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. The role of percutaneous left ventricular assist devices during ventricular tachycardia ablation. Bunch TJ; Mahapatra S; Madhu Reddy Y; Lakkireddy D Europace; 2012 Aug; 14 Suppl 2():ii26-ii32. PubMed ID: 22832915 [TBL] [Abstract][Full Text] [Related]
12. Implantable cardioverter-defibrillator shocks in patients with a left ventricular assist device. Ambardekar AV; Allen LA; Lindenfeld J; Lowery CM; Cannon AP; Cleveland JC; Brieke A; Sauer WH J Heart Lung Transplant; 2010 Jul; 29(7):771-6. PubMed ID: 20347337 [TBL] [Abstract][Full Text] [Related]
13. Endocardial catheter ablation of ventricular tachycardia in patients with ventricular assist devices. Dandamudi G; Ghumman WS; Das MK; Miller JM Heart Rhythm; 2007 Sep; 4(9):1165-9. PubMed ID: 17765615 [TBL] [Abstract][Full Text] [Related]
14. Extracorporeal Membrane Oxygenation for Hemodynamic Support of Ventricular Tachycardia Ablation. Baratto F; Pappalardo F; Oloriz T; Bisceglia C; Vergara P; Silberbauer J; Albanese N; Cireddu M; D'Angelo G; Di Prima AL; Monaco F; Paglino G; Radinovic A; Regazzoli D; Silvetti S; Trevisi N; Zangrillo A; Della Bella P Circ Arrhythm Electrophysiol; 2016 Dec; 9(12):. PubMed ID: 27932426 [TBL] [Abstract][Full Text] [Related]
15. Ventricular tachycardia ablation remains treatment of last resort in structural heart disease: argument for earlier intervention. Frankel DS; Mountantonakis SE; Robinson MR; Zado ES; Callans DJ; Marchlinski FE J Cardiovasc Electrophysiol; 2011 Oct; 22(10):1123-8. PubMed ID: 21539642 [TBL] [Abstract][Full Text] [Related]
16. Successful radiofrequency ablation therapy for intractable ventricular tachycardia with a ventricular assist device. Osaki S; Alberte C; Murray MA; Brahmbhatt RD; Johnson MR; Edwards NM; Kohmoto T J Heart Lung Transplant; 2008 Mar; 27(3):353-6. PubMed ID: 18342761 [TBL] [Abstract][Full Text] [Related]
17. Safety and Feasibility of Open Chest Epicardial Mapping and Ablation of Ventricular Tachycardia During the Period of Left Ventricular Assist Device Implantation. Patel M; Rojas F; Shabari FR; Simpson L; Cohn W; Frazier OH; Mallidi H; Cheng J; Mathuria N J Cardiovasc Electrophysiol; 2016 Jan; 27(1):95-101. PubMed ID: 26377813 [TBL] [Abstract][Full Text] [Related]
18. Influence of clinical and procedural predictors on ventricular tachycardia ablation outcomes: an analysis from the substrate mapping and ablation in Sinus Rhythm to Halt Ventricular Tachycardia Trial (SMASH-VT). Tung R; Josephson ME; Reddy V; Reynolds MR; J Cardiovasc Electrophysiol; 2010 Jul; 21(7):799-803. PubMed ID: 20132389 [TBL] [Abstract][Full Text] [Related]
19. Surgical ablation of post-infarction ventricular tachycardia guided by mapping in sinus rhythm: long term results. Pirk J; Bytesnik J; Kautzner J; Peichl P; Vancura V; Lefflerova K; Skalsky I; Vinduska V Eur J Cardiothorac Surg; 2004 Aug; 26(2):323-9. PubMed ID: 15296891 [TBL] [Abstract][Full Text] [Related]
20. Clinical impact of concomitant tricuspid valve procedures during left ventricular assist device implantation. Piacentino V; Troupes CD; Ganapathi AM; Blue LJ; Mackensen GB; Swaminathan M; Felker GM; Stafford-Smith M; Lodge AJ; Rogers JG; Milano CA Ann Thorac Surg; 2011 Oct; 92(4):1414-8; discussion 1418-9. PubMed ID: 21958790 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]